South Korea’s Doping Control Center South Korea’s Doping Control Center will rely on Agilent 7000 Triple Quadrupole GC/MS and 7010 Triple Quadrupole GC/MS systems to run up to 4,000 urine tests during multiple work shifts. Established by the Korea Institute of Science and Technology in 1984, the center is an accredited lab of the World Anti-Doping Agency.Image courtesy of Agilent Technologies

SANTA CLARA, Calif., Feb. 8, 2018

Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the Doping Control Center in Seoul, South Korea, to ensure that athletes from around the world are quickly and accurately tested to determine whether any have been using banned substances to enhance their performances.

Agilent has been a major supplier of analytical instruments to the center since 1984. During events this winter, the company will have certified engineers on standby around the clock to ensure the highest level of service. The center is expected to run 4,000 urine tests during multiple work shifts.

“To ensure the most reliable performance of instruments during this critical drug-testing period, strong and timely support from Agilent is essential,” said Oh-Seung Kwon, PhD, director and principal research scientist at the Doping Control Center.

Established by the Korea Institute of Science and Technology in 1984, the center is an accredited lab of the World Anti-Doping Agency.

Agilent systems are highly automated to provide rapid test results at a glance, enabling the use of screening methods for identifying banned substances in sport.

In addition to providing advanced instrumentation, Agilent also helps labs develop further methods for detecting banned substances, trains investigators, and provides technical support and maintenance of the instruments.

“We are pleased that Agilent can provide emergency support resources and systems to protect the athletes' health and induce fair competition,” said Jong-Gon Kim, country service business manager at Agilent Technologies Korea.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 13,500 people worldwide. Information about Agilent is available at www.agilent.com.